Scythian Biosciences Corp. said its stock will start trading on the Canadian Securities Exchange starting Aug. 15.

The Toronto-based cannabis company's stock, which is also listed in Frankfurt and the OTC Market, will trade under the symbol SCYB.

"The TSX Venture Exchange policies required that we delist from the exchange prior to completion of any acquisitions of United States based cannabis companies. With our strategic expansion into the United States, it was determined best to delist from the TSX Venture Exchange at this point in time," Scythian CEO Rob Reid said in a statement.